D.E. Shaw & Co
BSTC

D.E. Shaw & Co’s BioSpecifics Technologies Corp. BSTC Stock Holding History

D.E. Shaw & Co’s Portfolio BSTC Stock Details BSTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-4,869
Closed -$298K – 4327
2020
Q2 		$298K Sell
4,869
-500
-9% -$28.9K ﹤0.01% 3632
2020
Q1 		$304K Sell
5,369
-1,400
-21% -$79.8K ﹤0.01% 3463
2019
Q4 		$385K Hold
6,769
– – ﹤0.01% 3524
2019
Q3 		$362K Hold
6,769
– – ﹤0.01% 3361
2019
Q2 		$404K Buy
6,769
+3,319
+96% +$209K ﹤0.01% 3173
2019
Q1 		$215K Sell
3,450
-4,354
-56% -$288K ﹤0.01% 3380
2018
Q4 		$473K Sell
7,804
-4,257
-35% -$254K ﹤0.01% 3123
2018
Q3 		$705K Sell
12,061
-540
-4% -$27.6K ﹤0.01% 2910
2018
Q2 		$565K Buy
12,601
+2,165
+21% +$93.1K ﹤0.01% 3044
2018
Q1 		$463K Buy
10,436
+900
+9% +$37.8K ﹤0.01% 2923
2017
Q4 		$413K Buy
9,536
+4,005
+72% +$180K ﹤0.01% 3088
2017
Q3 		$257K Buy
+5,531
New +$265K ﹤0.01% 3204

Other funds holding BSTC

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

D.E. Shaw & Co's BSTC Position: Q3 2020 in Review

D.E. Shaw & Co sold out of BioSpecifics Technologies Corp. (BSTC) in Q3 2020, closing a stake of 4,869 shares — an estimated $298K sold.

D.E. Shaw & Co first reported a position in BSTC in Q3 2017 and held it in 12 quarters. The position peaked at $705K in Q3 2018. 113 funds tracked by Wall St. Rank hold BSTC as of Q3 2020.

  • D.E. Shaw & Co reported no remaining BioSpecifics Technologies Corp. position as of Q3 2020 after selling out during the quarter.
  • D.E. Shaw & Co sold 4,869 BioSpecifics Technologies Corp. shares in Q3 2020, an estimated $298K.
  • D.E. Shaw & Co first reported a position in BioSpecifics Technologies Corp. in Q3 2017 and held it in 12 quarters.
  • D.E. Shaw & Co's BioSpecifics Technologies Corp. position peaked at $705K in Q3 2018.
  • 113 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q3 2020.

Based on D.E. Shaw & Co's 13F filing for Q3 2020, filed 16 Nov 2020.